Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Furosemide

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Solution) Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Jun 22, 2026, 10:41 a.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Jun 22, 2026, 10:41 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Jun 21, 2026, 5:14 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Image coming soon
Furosemide

Furosemide

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Liquid (Solution) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Furosemide

Diuretic used to manage fluid overload (commonly in heart failure). Species commonly shown: Both, Dog, Horse, Not For Meat Production.

Generic name
Furosemide
Brand names
Furosemide Injection 5%, Furosemide Syrup 1%, Furosemide Tablets, Salix®
Manufacturer
Multiple FDA labelers
Species
Both, Dog, Horse, Cat
Dosage forms
Liquid (Solution), Syrup, Liquid, Tablet
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Furosemide Injection 5% Furosemide Syrup 1% Furosemide Tablets Salix® Salix® Tablets Lasix® Packets Furos-A-Vet Lasix® Syrup 1% Disal® Disal® Injection Furosemide Disal Salix Furosemide 1%
Dosage forms
Liquid (Solution) Syrup Liquid Tablet Powder

Indications / Uses

Diuretic used to manage fluid overload (commonly in heart failure).

Administration / How To Give

Oral / Injectable

Storage

Store at room temperature.

Warnings / Contraindications

Use caution with dehydration, kidney disease, or electrolyte imbalances.

  • Use caution with dehydration, kidney disease, or electrolyte imbalances.

Side Effects

Increased urination, dehydration, electrolyte changes.

FAQ

Both, Dog, Horse, Not For Meat Production, Cat, Cows

Yes. Roxee shows this as prescription-only.

Liquid (Solution), Syrup, Liquid, Tablet

Store at room temperature.

Related Medications

Ivermectin Same category: Heart Pimobendan Same category: Heart Phenobarbital Same category: Deworming Cephalexin Same category: Heart Imidacloprid Same category: Heart Ivermectin, Pyrantel Same category: Heart

Related Conditions

Ascites (hepatic) Dehydration

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Use caution with dehydration, kidney disease, or electrolyte imbalances
  • Loss of appetite (1 reports)
  • Dry coat (1 reports)
  • Drooling (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Furosemide; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2025-US-074687
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 26 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2025-US-074687
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2025-US-074687
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Loss of appetite (1 reports), Dry coat (1 reports), Drooling (1 reports), Discoloured urine (1 reports), Dehydration (1 reports)

Body systems represented Signal grouping

Digestive (5), Skin & allergy (1), Neurologic (2), Behavior (1)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (16 reports), Cat (16 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (2), ['Maltese', 'Poodle - Miniature'] (1), Crossbred Canine/dog (1), Terrier - Yorkshire (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Furosemide fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Use caution with dehydration, kidney disease, or electrolyte imbalances, Loss of appetite, Dry coat, Drooling

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Furosemide brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2025-US-074687 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. SPL · document · documents
  8. SPL · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: February 12, 2026, 7:40 PM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Use caution with dehydration, kidney disease, or electrolyte imbalances
  • Loss of appetite
  • Dry coat
  • Drooling

Most reported reactions:

  • Loss of appetite (1 reports)
  • Dry coat (1 reports)
  • Drooling (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Cat, Cows, Dog, Horse
Indication / use
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Form / route / dose
Form: Liquid, Liquid (Solution), Powder, Syrup, Tablet
Route: Intramuscular, Intravenous, Oral
Confirm product label and patient-specific plan.
Warnings
  • High: Use caution with dehydration, kidney disease, or electrolyte imbalances.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Form: Liquid, Liquid (Solution), Powder, Syrup, Tablet
Identifiers:
ANADA: 200293 ANADA: 200373 ANADA: 200382 ANADA: 200759 NADA: 102380 NADA: 118550 NADA: 125329 NADA: 127034 NADA: 129034 NADA: 131538 NADA: 131806 NADA: 34478 NADA: 34621 NADA: 45188 NDC Package: 0010-6737-01 NDC Package: 0010-6738-01 NDC Package: 0010-6739-01 NDC Package: 11695-0090-5 NDC Package: 11695-0091-5 NDC Package: 11695-0092-1
Source metadata:

Warnings / Contraindications

Use caution with dehydration, kidney disease, or electrolyte imbalances.

  • High: Use caution with dehydration, kidney disease, or electrolyte imbalances.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
19
Matching reports
2
Active filters
2
Selected filters
Reaction: Collapse NOS (see also Cardio-vascular and Neurological disorders) Clear Body system: Digestive Clear
Reset
Drill into common report signals
Vomiting (4) Circling - neurological disorder (see also Behavioural disorders) (2) Collapse NOS (see also Cardio-vascular and Neurological disorders) (2) Death by euthanasia (2) Other (17) Neurologic (9) Digestive (7) Skin & allergy (1)
Showing up to 50 matching reports.

USA-USFDACVM-2025-US-075485

Received 2025-11-24 · MSK · MSK

Serious
Species
Dog
Breed
['Shih Tzu', 'Dog (unknown)']
Size / weight
Under 10 lb (3.901 Kilogram)
Age
8+ years (16 Year)
Sex
Male Neutered
Region
USA
Reactions
Collapse NOS (see also Cardio-vascular and Neurological disorders)VocalisationDroolingCircling - neurological disorder (see also Behavioural disorders)KnucklingUnable to walkDeath by euthanasia
Body systems
NeurologicOtherDigestive
Outcomes
Euthanized

USA-USFDACVM-2025-US-066054

Received 2025-11-03 · MSK · MSK

Serious
Species
Dog
Breed
['Shih Tzu', 'Dog (unknown)']
Size / weight
Under 10 lb (3.901 Kilogram)
Age
8+ years (16 Year)
Sex
Male Neutered
Region
USA
Reactions
Collapse NOS (see also Cardio-vascular and Neurological disorders)VocalisationDroolingCircling - neurological disorder (see also Behavioural disorders)KnucklingUnable to walkDeath by euthanasia
Body systems
NeurologicOtherDigestive
Outcomes
Euthanized

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (5) · Loss of appetite, Drooling, Diarrhea Skin & allergy (1) · Biting - pruritus Neurologic (2) · Unsteady walking (ataxia), Circling - neurological disorder Behavior (1) · Behavioral disorder (unspecified) Other (23) · Dry coat, Discoloured urine, Difficulty standing
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Digestive 1 Dog 1
Other 1 Cat 1
Digestive 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Digestive 1 Cat 1

Species coverage: Dog (16) Cat (16)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Non-serious - 1
Digestive Dog Serious - 1
Other Cat Serious - 1
Digestive Dog Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Digestive Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Digestive Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Neurologic Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Skin & allergy Cat Non-serious - 1
Other Cat Serious - 1
Behavior Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Digestive Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Source metadata:

Storage & Handling

Store at room temperature.

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Furosemide Tablets SPL · SPL Salix® SPL · SPL Furos-A-Vet SPL · SPL

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

29

FOI

4

Furosemide Tablets

SPL · SPL

Open original
FDA Structured Product Label

Furosemide Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
ZYVET AH, Inc.
ANADA
200-759
Status
RX
Form
Tablet
Route
Oral
Composition / specifications
12.5 mg or 50 mg furosemide/tablet

Dogs and cats

Indication

For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.

Dosage

1 to 2 mg/lb body weight (approximately 2.5 to 5 mg/kg). The lower dosage is suggested for cats. Administer once or twice daily at 6 to 8 hour intervals either orally, intravenously, or intramuscularly.

Salix®

SPL · SPL

Open original
FDA Structured Product Label

Salix®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
34478
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse • Cows • Cat
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.

Cattle

Indication
It is used for the treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 500 milligrams per animal once daily or 250 milligrams per animal twice daily at 12-hour intervals, treatment not to exceed 48 hours post parturition.
Limitations
Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment. The drug if given in excessive amounts may result in dehydration and electrolyte imbalance. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval. The lower dosage is suggested for cats. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
For the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency, and acute noninflammatory tissue edema.
Dosage
250 to 500 mg/animal once or twice daily, intramuscularly or intravenously.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Furos-A-Vet

SPL · SPL

Open original
FDA Structured Product Label

Furos-A-Vet

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
118-550
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous
Species
Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.

Horses

Indication
It is used for treatment of acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 0.5 milligram per pound of body weight (1.0 milligram per kilogram); once or twice daily at 6-to 8-hour intervals.
Limitations
Do not use in horses intended for food. The dosage should be adjusted to the individual's response. In refractory or severe edematous cases, the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule, i.e., every other day or 2 to 4 consecutive days weekly. Concurrent therapy for treatment of systemic conditions causing edema (pulmonary congestion, ascites, cardiac insufficiency) should be instituted.

Disal® Injection

SPL · SPL

Open original
FDA Structured Product Label

Disal® Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA, Inc.
NADA
127-034
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous
Species
Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide monoethanolamine.

Horses

Indication
It is used for treatment of acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 0.5 milligram per pound of body weight (1.0 milligram per kilogram); once or twice daily at 6- to 8-hour intervals.
Limitations
Do not use in horses intended for food. The dosage should be adjusted to the individual's response. In refractory or severe edematous cases, the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule, i.e., every other day or 2 to 4 consecutive days weekly. Concurrent therapy for treatment of systemic conditions causing edema (pulmonary congestion, ascites, cardiac insufficiency) should be instituted.

Disal®

SPL · SPL

Open original
FDA Structured Product Label

Disal®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA, Inc.
NADA
129-034
Status
RX
Form
Tablet
Route
Oral
Species
Dog • Cat
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Disal®

SPL · SPL

Open original
FDA Structured Product Label

Disal®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA, Inc.
NADA
131-538
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide monoethanolamine.

Dogs

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval.

Indications: It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.

Limitations
The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.

Horses

Indication
For treatment of acute noninflammatory tissue edema.
Dosage
0.5 mg/lb body weight once or twice daily, intramuscularly or intravenously.
Limitations
Do not use in horses intended for human consumption. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 0.5 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.

Furosemide Injection 5%

SPL · SPL

Open original
FDA Structured Product Label

Furosemide Injection 5%

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Elanco US Inc.
ANADA
200-293
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.

Horses

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 250 to 500 milligrams per animal once or twice daily.
Limitations
Do not use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication
It is used for the treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
500 milligrams per animal once daily, intramuscularly or intravenously; or 250 milligrams per animal twice daily at 12-hour intervals, intramuscularly or intravenously.
Limitations
Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment.

Dogs

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1.25 to 2.5 mg per pound (/lb) body weight once or twice daily, intramuscularly or intravenously.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1.25 to 2.5 mg per pound (/lb) body weight once or twice daily, intramuscularly or intravenously.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Furosemide Syrup 1%

SPL · SPL

Open original
FDA Structured Product Label

Furosemide Syrup 1%

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
First Priority, Inc.
ANADA
200-373
Status
RX
Form
Syrup
Route
Oral
Species
Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Furosemide Syrup 1%

SPL · SPL

Open original
FDA Structured Product Label

Furosemide Syrup 1%

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Cronus Pharma Specialities India Private Ltd.
ANADA
200-382
Status
RX
Form
Liquid
Route
Oral
Species
Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Furosemide Tablets

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Furosemide Tablets

SPL · SPL

Open original
FDA Structured Product Label

Furosemide Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Teva Animal Health, Inc.
NADA
131-806
Status
RX
Form
Tablet
Route
Oral
Species
Dog
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Lasix® Packets

SPL · SPL

Open original
FDA Structured Product Label

Lasix® Packets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
45188
Status
RX
Form
Powder
Route
Oral
Composition / specifications
Each bolus or packet of powder contains 2 grams furosemide.

Cattle (dairy)

Indication
For treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
1 to 2 milligram per pound body weight using powder, or one 2-gram bolus per animal, per day.
Limitations
Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Lasix® Syrup 1%

SPL · SPL

Open original
FDA Structured Product Label

Lasix® Syrup 1%

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
102-380
Status
RX
Form
Syrup
Route
Oral
Species
Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Salix® Tablets

SPL · SPL

Open original
FDA Structured Product Label

Salix® Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
34621
Status
RX
Form
Tablet
Route
Oral
Species
Dog • Cows • Cat
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.

Cats

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Disal SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Disal. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Disal SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Disal. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Furosemide 1% SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide 1%. Use the source link for the full official labeling record.

Salix SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Salix. Use the source link for the full official labeling record.

Furosemide 1% SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide 1%. Use the source link for the full official labeling record.

Furosemide 1% SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide 1%. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Salix SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Salix. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

Furosemide SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Furosemide. Use the source link for the full official labeling record.

FOI Summary oA 200-759 Approved July 18, 2025.pdf

FOI · FOI

Open original

ucm061739.pdf

FOI · FOI

Open original

ucm059305.pdf

FOI · FOI

Open original

ucm061337.pdf

FOI · FOI

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Disal Furosemide Furosemide 1% Salix
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Cows, Dog, Horse
Rx/OTC: RX
Form/route: Liquid, Liquid (Solution), Powder, Syrup, Tablet • Intramuscular, Intravenous, Oral
Applications: ANADA 200-759 • NADA 34478 • NADA 118-550 • NADA 127-034 • NADA 129-034 • NADA 131-538 • ANADA 200-293 • ANADA 200-373 • ANADA 200-382 • NADA 125-329 • NADA 131-806 • NADA 45188 • NADA 102-380 • NADA 34621
NDC: Packages 0010-6737-01 0010-6738-01 0010-6739-01 11695-0090-5 11695-0091-5 11695-0092-1 • Products 0010 11695 13985 57926 58829 73309
Documents: 4 (FOI: 4) • SPL: 14 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 41 • Cat 50 • View
Case summaries: 19 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Related conditions: Ascites (hepatic) Dehydration
Linked using: Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Use caution with dehydration, kidney disease, or electrolyte imbalances. (Contraindication, High)
Top reaction signals
Loss of appetite (1) Dry coat (1) Drooling (1) Discoloured urine (1) Dehydration (1) Decreased haematocrit (1) Decreased blood urea nitrogen (BUN) or creatinine (1) Decreased appetite (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200293 ANADA: 200373 ANADA: 200382 ANADA: 200759 NADA: 102380 NADA: 118550 NADA: 125329 NADA: 127034 NADA: 129034 NADA: 131538 NADA: 131806 NADA: 34478 NADA: 34621 NADA: 45188 NDC Package: 0010-6737-01 NDC Package: 0010-6738-01 NDC Package: 0010-6739-01 NDC Package: 11695-0090-5 NDC Package: 11695-0091-5 NDC Package: 11695-0092-1 NDC Package: 11695-2222-2 NDC Package: 13985-303-60 NDC Package: 13985-581-10 NDC Package: 13985-585-50
Package NDC Product NDC Form / Route Status
0010-6737-01 0010 -
0010-6738-01 0010 -
0010-6739-01 0010 -
11695-0090-5 11695 -
11695-0091-5 11695 -
11695-0092-1 11695 -
11695-2222-2 11695 -
13985-303-60 13985 -
13985-581-10 13985 -
13985-585-50 13985 -
13985-586-12 13985 -
57926-463-30 57926 -
57926-464-31 57926 -
57926-465-01 57926 -
58829-303-60 58829 -
73309-064-01 73309 -
73309-064-02 73309 -
73377-163-01 73377 -
73377-163-03 73377 -
86117-016-12 86117 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Disal SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Disal SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide 1% SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Salix SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide 1% SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide 1% SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Salix SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Furosemide SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • FOI Summary oA 200-759 Approved July 18, 2025.pdf • FOI summary • Official • July 31, 2025
    FDA FOI summary for application 200759
  • ucm061337.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200382
  • ucm059305.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200373
  • ucm061739.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200293

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 135 Clinical 4 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Increased urination, dehydration, electrolyte changes. (Clinical, 2026-04-11)
  • storage_handling: Store at room temperature. (Clinical, 2026-04-12)
  • storage_handling: Store at room temperature. (Clinical, 2026-04-11)
  • storage_handling: Store at room temperature. (Clinical, 2026-02-12)
  • contraindications: Use caution with dehydration, kidney disease, or electrolyte imbalances. (Official, 2026-04-12)
  • contraindications: Use caution with dehydration, kidney disease, or electrolyte imbalances. (Official, 2026-04-11)
  • contraindications: Use caution with dehydration, kidney disease, or electrolyte imbalances. (Official, 2026-02-12)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-22)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-22)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-21)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-20)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-13)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-12)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-12)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-11)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-11)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-10)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-09)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-08)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-06-07)
Recent Revisions
  • side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Furosemide Tablets
RX
Furosemide
Tablet • Oral
Label highlights
Official documents
ZYVET AH, Inc. ANADA 200-759 Approved Jul 31, 2025
Salix®
RX
Furosemide
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Intervet, Inc. NADA 34478 Approved Feb 25, 2025
Furos-A-Vet
RX
Furosemide
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 118-550 Approved Oct 2, 2018
Disal® Injection
RX
Furosemide
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Boehringer Ingelheim Animal Health USA, Inc. NADA 127-034 Approved Nov 13, 2017
Disal®
RX
Furosemide
Tablet • Oral
Label highlights
Official documents
Boehringer Ingelheim Animal Health USA, Inc. NADA 129-034 Approved Jun 1, 2016
Disal®
RX
Furosemide
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Boehringer Ingelheim Animal Health USA, Inc. NADA 131-538 Approved Jun 1, 2016
Furosemide Injection 5%
RX
Furosemide
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Elanco US Inc. ANADA 200-293 Approved Jun 1, 2016
Furosemide Syrup 1%
RX
Furosemide
Syrup • Oral
Label highlights
Official documents
First Priority, Inc. ANADA 200-373 Approved Jun 1, 2016
Furosemide Syrup 1%
RX
Furosemide
Liquid • Oral
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. ANADA 200-382 Approved Jun 1, 2016
Furosemide Tablets
RX
Furosemide
Official documents
Bolar Pharmaceutical Co., Inc. NADA 125-329 W Jun 1, 2016
Furosemide Tablets
RX
Furosemide
Tablet • Oral
Label highlights
Official documents
Teva Animal Health, Inc. NADA 131-806 W Jun 1, 2016
Lasix® Packets
RX
Furosemide
Powder • Oral
Label highlights
Official documents
Intervet, Inc. NADA 45188 Approved Jun 1, 2016
Lasix® Syrup 1%
RX
Furosemide
Syrup • Oral
Label highlights
Official documents
Intervet, Inc. NADA 102-380 Approved Jun 1, 2016
Salix® Tablets
RX
Furosemide
Tablet • Oral
Label highlights
Official documents
Intervet, Inc. NADA 34621 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
12.5 mg or 50 mg furosemide/tablet
Dogs and cats
Indication

For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.

Dosage

1 to 2 mg/lb body weight (approximately 2.5 to 5 mg/kg). The lower dosage is suggested for cats. Administer once or twice daily at 6 to 8 hour intervals either orally, intravenously, or intramuscularly.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cows • Cat
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.
Cattle
Indication
It is used for the treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 500 milligrams per animal once daily or 250 milligrams per animal twice daily at 12-hour intervals, treatment not to exceed 48 hours post parturition.
Limitations
Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment. The drug if given in excessive amounts may result in dehydration and electrolyte imbalance. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval. The lower dosage is suggested for cats. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
For the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency, and acute noninflammatory tissue edema.
Dosage
250 to 500 mg/animal once or twice daily, intramuscularly or intravenously.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.
Horses
Indication
It is used for treatment of acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 0.5 milligram per pound of body weight (1.0 milligram per kilogram); once or twice daily at 6-to 8-hour intervals.
Limitations
Do not use in horses intended for food. The dosage should be adjusted to the individual's response. In refractory or severe edematous cases, the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule, i.e., every other day or 2 to 4 consecutive days weekly. Concurrent therapy for treatment of systemic conditions causing edema (pulmonary congestion, ascites, cardiac insufficiency) should be instituted.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide monoethanolamine.
Horses
Indication
It is used for treatment of acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 0.5 milligram per pound of body weight (1.0 milligram per kilogram); once or twice daily at 6- to 8-hour intervals.
Limitations
Do not use in horses intended for food. The dosage should be adjusted to the individual's response. In refractory or severe edematous cases, the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule, i.e., every other day or 2 to 4 consecutive days weekly. Concurrent therapy for treatment of systemic conditions causing edema (pulmonary congestion, ascites, cardiac insufficiency) should be instituted.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide monoethanolamine.
Dogs
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
The drug is administered intramuscularly or intravenously at a dosage of 12.5 to 25 milligrams per 10 pounds of body weight; once or twice daily after a 6- to 8-hour interval.

Indications: It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.

Limitations
The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 1 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.
Horses
Indication
For treatment of acute noninflammatory tissue edema.
Dosage
0.5 mg/lb body weight once or twice daily, intramuscularly or intravenously.
Limitations
Do not use in horses intended for human consumption. The dosage should be adjusted to the individual animal's response. In refractory or severe edematous cases the dosage may be doubled or increased by increments of 0.5 milligram per pound of body weight to establish the effective dose. The established effective dose should be administered once or twice daily on an intermittent daily schedule. Diuretic therapy should be discontinued after reduction of edema, or when necessary, maintained after determining a programmed dosage schedule to prevent recurrence.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile solution contains 50 milligrams of furosemide diethanolamine.
Horses
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
Administer intramuscularly or intravenously at 250 to 500 milligrams per animal once or twice daily.
Limitations
Do not use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cattle
Indication
It is used for the treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
500 milligrams per animal once daily, intramuscularly or intravenously; or 250 milligrams per animal twice daily at 12-hour intervals, intramuscularly or intravenously.
Limitations
Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment.
Dogs
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1.25 to 2.5 mg per pound (/lb) body weight once or twice daily, intramuscularly or intravenously.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1.25 to 2.5 mg per pound (/lb) body weight once or twice daily, intramuscularly or intravenously.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Composition / specifications
Each bolus or packet of powder contains 2 grams furosemide.
Cattle (dairy)
Indication
For treatment of physiological parturient edema of the mammary gland and associated structures.
Dosage
1 to 2 milligram per pound body weight using powder, or one 2-gram bolus per animal, per day.
Limitations
Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
Each milliliter of syrup contains 10 milligrams furosemide.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cows • Cat
Composition / specifications
Each tablet contains 12.5 or 50 milligrams furosemide.
Cats
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
Dosage
1 to 2 milligrams per pound of body weight, once or twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

Diuretic used to manage fluid overload (commonly in heart failure).

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Use caution with dehydration, kidney disease, or electrolyte imbalances.

Side Effects

Increased urination, dehydration, electrolyte changes.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Dog Drooling (1) • Dog Diarrhea (1) • Cat Decreased appetite (1) • Cat Appetite disorder NOS (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Biting - pruritus (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog Circling - neurological disorder (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Other
Dry coat (1) • Cat Discoloured urine (1) • Cat Difficulty standing (1) • Dog Dehydration (1) • Dog Decreased haematocrit (1) • Cat
Show more (18)
Decreased blood urea nitrogen (BUN) or creatinine (1) • Dog Death by euthanasia (1) • Cat Death (1) • Dog Deafness (1) • Dog Crackles on auscultation (1) • Dog Cough, productive (1) • Cat Cough (1) • Cat Congestive heart failure (1) • Cat Collapse NOS (1) • Dog Cognitive disorder NOS (1) • Dog Cardiac arrest (1) • Cat Breathing difficulty (1) • Cat Bilirubinuria (1) • Cat Basophilia (1) • Cat Barking (1) • Dog Anaemia NOS (1) • Cat Abnormal radiograph finding (1) • Cat Abnormal adrenocorticotropic hormone (ACTH) stimulation test (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Female, 7 month, 3.08 kilogram • Drug: MSK, Unknown • Reactions: Fever, Cough, productive, Weight loss, Breathing difficulty, Abnormal radiograph finding… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-075237
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 7.00 Month
  • Weight: 3.080 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Fever Cough, productive Weight loss Breathing difficulty Abnormal radiograph finding Pulmonary disorder NOS Tiredness (lethargy) Sedation Kidney atrophy Bilirubinuria Elevated mean corpuscular haemoglobin concentration Enlarged kidney Elevated mean corpuscular volume Eosinopenia Low serum alkaline phosphatase Neutropenia Discoloured urine Monocytosis Lymphopenia Elevated amylase Elevated alanine aminotransferase Low creatinine Hyponatremia Other abnormal test result NOS Elevated total bilirubin Hyperglycaemia Lymphocytosis Neutrophilia Leucocytosis NOS Basophilia
Outcomes: Recovered/Normal

Dog, ['Maltese', 'Poodle - Miniature'], Female, 13 year, 4.75 kilogram • Drug: MSK, Unknown • Reactions: Elevated serum alkaline phosphatase, Seizure NOS, Hypocortisolaemia, Abnormal adrenocorticotropic hormone (ACTH) stimulation test, Syncope… • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-074687
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 13.00 Year
  • Weight: 4.750 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Elevated serum alkaline phosphatase Seizure NOS Hypocortisolaemia Abnormal adrenocorticotropic hormone (ACTH) stimulation test Syncope Barking Lying down
Outcomes: Outcome Unknown

Cat, Domestic Shorthair, Male, 6 year, 4.6 kilogram • Drug: MSK, Oral, Dose: 5 Milligram per animal, Frequency: 12 per hour • Reactions: Diarrhea • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-074006
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 6.00 Year
  • Weight: 4.600 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 5 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Diarrhea
Outcomes: Outcome Unknown

Dog, Crossbred Canine/dog, Female, 13 year • Drug: MSK, Oral, Dose: 30 Milligram per animal, Frequency: 12 per hour • Reactions: Vomiting • Outcome: Outcome Unknown

  • Report ID: PRT-USFDACVM-2025-PT-000010
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 13.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 30 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Vomiting
Outcomes: Outcome Unknown

Dog, Terrier - Yorkshire, Female, 13.5 year, 2.8 kilogram • Drug: MSK, Unknown • Reactions: Pale mucous membrane, Laboured breathing, Increased respiratory rate, Crackles on auscultation, Prolonged capillary refill time… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-072177
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 13.50 Year
  • Weight: 2.800 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Pale mucous membrane Laboured breathing Increased respiratory rate Crackles on auscultation Prolonged capillary refill time Other abnormal test result NOS
Outcomes: Ongoing

Dog, ['Spaniel - King Charles Cavalier', 'Spaniel - Cocker American'], Female, 13 year, 11.79 kilogram • Drug: MSK, Unknown • Reactions: Difficulty standing, Nausea, Hind limb ataxia, Vomiting • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-072043
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 13.00 Year
  • Weight: 11.790 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Difficulty standing Nausea Hind limb ataxia Vomiting
Outcomes: Recovered/Normal

Dog, Maltese, Female, 14 year • Drug: MSK, Oral, Dose: 5 Milligram per animal, Frequency: 12 per hour • Reactions: Unsteady walking (ataxia), Tremors, Peripheral vestibular disorder • Outcome: Recovered/Normal

  • Report ID: DEU-USFDACVM-2025-DE-000061
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 14.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 5 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Unsteady walking (ataxia) Tremors Peripheral vestibular disorder
Outcomes: Recovered/Normal

Cat, Ragdoll, Female, 2 year, 4.6 kilogram • Drug: MSK, Oral, Dose: 1.14 Milligram per kilogram, Frequency: 12 per hour • Reactions: Ketonuria, Increased weight • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-073438
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 2.00 Year
  • Weight: 4.600 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 1.14 Milligram per kilogram
  • Frequency: 12 per hour
Reactions Reported:
Ketonuria Increased weight
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.